pone.0279333.g002.tif (622.93 kB)
Cumulative incidence of adverse cardiovascular events and serious cardiac arrythmias in the COVID-19 and control cohorts.
figure
posted on 2022-12-30, 18:27 authored by Luis Ortega-Paz, Victor Arévalos, Diego Fernández-Rodríguez, Víctor Jiménez-Díaz, Jordi Bañeras, Gianluca Campo, Miguel Rodríguez-Santamarta, José Francisco Díaz, Claudia Scardino, Zaira Gómez-Álvarez, Alberto Pernigotti, Fernando Alfonso, Ignacio J. Amat-Santos, Antonio Silvestro, Lorenzo Rampa, José M. de la Torre Hernández, Gabriela Bastidas, Josep Gómez-Lara, Behnood Bikdeli, Hector M. García-García, Dominick J. Angiolillo, Josep Rodés-Cabau, Manel Sabaté, Salvatore BrugalettaCumulative 1-year incidences are shown with Kaplan-Meier event rates with 95% CI. (A1 and B1) Entire study comprised from 0–365 days and (A2 and B2) post-acute phase from 31–365 days. Adj HR, adjusted hazard ratio; 95%CI, 95% confidence interval.
History
Usage metrics
Categories
Keywords
without suggestive symptomstime reverse transcriptaseserious cardiac arrhythmiasprespecified landmark analysispolymerase chain reactionnasopharyngeal swab resultdeep vein thrombosiscoronavirus disease 201999 &# 821193 &# 821156 &# 821135 &# 821131 &# 821125 &# 821102 &# 821199 ]; p91 ]; p70 ]; p46 ]; ptwo cohorts depending0 %; hr6 %, hr0 ]; p0 %; p8 %; hr8 %, hr6 %; p7 %; hr4 %, hr80 ]; padverse cv events19 cohort compared044 ), vteyear cardiovascular outcomesassess eventsterm cardiovascular19 cohort8 %)vte ),555 ),425 ),001 ),control cohortsxlink ">unique identifiersignificant differencesprimary outcomeprimary endpointincreased riskhospitalization ratehigher riskhigher rateselectronic recordsdecember 2020cv deathcontrol cohortcomparing outcomesclinical statusclinical followcause deathcardiovascular covidbaseline characteristicsacute phase19 experienced18 years028 ).010 ).001 ).
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC